Published in Asia Ocean J Nucl Med Biol on January 01, 2015
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology (1999) 5.64
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med (2003) 2.52
Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol (1997) 1.47
18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus? Nucl Med Commun (2011) 1.44
Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl (2010) 1.38
Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci (2007) 1.31
Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging (2007) 1.20
Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med (2010) 1.18
Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesions. AJR Am J Roentgenol (2007) 1.09
The situation with cancer control in Vietnam. Jpn J Clin Oncol (2002) 1.06
Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol (2008) 1.01
Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol (2008) 1.01
Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98
Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma. World J Gastroenterol (2007) 0.96
Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. AJR Am J Roentgenol (2013) 0.94
High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC Gastroenterol (2011) 0.92
Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol (2008) 0.91
The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdom Imaging (2014) 0.90
Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.89
Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence. Anticancer Res (2005) 0.88
The value of contrast enhanced ultrasound in the evaluation of the nature of portal vein thrombosis. Med Ultrason (2011) 0.84
The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom. Hepatogastroenterology (2009) 0.83
Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics. Acta Med Okayama (2012) 0.82
Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in (18)F-FDG PET/CT. Nucl Med Commun (2014) 0.79
Extensive tumor thrombus of hepatocellular carcinoma in the entire portal venous system detected on fluorodeoxyglucose positron emission tomography computed tomography. Indian J Nucl Med (2013) 0.77
(18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases. Asia Ocean J Nucl Med Biol (2014) 0.75